The main target of Pharmaco Genomics panels are the genes associated with prescribed drugs of the corresponding diseases. The assay allows for precise selection and dosage of prescribed FDA approved druugs, and detection of genetic varriants associated with drug metabolism in Oncologyn Neurology, Cardiology, tuberculosis and many diseases.
| Gene count/ family | ~122 |
| Covered region | Whole CDS + UTR(-50bp, +10bp) |
| Target size | 0.6 Mb |
| Mutation type | SNV/ InDels |
| Sample type | Blood |
| Features | Illumina | MGI | Thermofisher |
|---|---|---|---|
| Coverage uniformity | 94% | 93% | 83% |
| Precision | 98% | 98% | 84% |
| Reproducibility | 98% | 98% | 98% |
| Sensitivity | >90% | >91% | >77% |
| On Target Ratio | 88-95% | 87-95% | 74-85% |
| Ordering Information | |
|---|---|
| Commercial Name | Cat No. |
| Pharamco Genomics | G2MMSP08001-ill |
| Pharamco Genomics | G2MMSP08001-MG |
| Pharamco Genomics | G2MMSP08001-TF |
Download useful documents and technical information for Pharmaco-genomics.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
